{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:30:34Z","timestamp":1788838234627,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81102689"],"award-info":[{"award-number":["81102689"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071542"],"award-info":[{"award-number":["82071542"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2021CFB381"],"award-info":[{"award-number":["2021CFB381"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11011-022-00917-6","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T04:02:41Z","timestamp":1643342561000},"page":"1669-1681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Age-dependent aggregation of \u03b1-synuclein in the nervous system of gut-brain axis is associated with caspase-1 activation"],"prefix":"10.1007","volume":"37","author":[{"given":"Qi","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1025-164X","authenticated-orcid":false,"given":"Xiaofan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir N.","family":"Uversky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Pan-Montojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suiqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"issue":"1","key":"917_CR1","first-page":"29","volume":"56","author":"A Adamczyk","year":"2005","unstructured":"Adamczyk A, Solecka J, Strosznajder JB (2005) Expression of alpha-synuclein in different brain parts of adult and aged rats. J Physiol Pharmacol 56(1):29\u201337","journal-title":"J Physiol Pharmacol"},{"issue":"6","key":"917_CR2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/mds.25421","volume":"28","author":"S Appel-Cresswell","year":"2013","unstructured":"Appel-Cresswell S et al (2013) Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson\u2019s disease. Mov Disord 28(6):811\u20133. https:\/\/doi.org\/10.1002\/mds.25421","journal-title":"Mov Disord"},{"issue":"3","key":"917_CR3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1172\/jci76307","volume":"125","author":"M Avetisyan","year":"2015","unstructured":"Avetisyan M, Schill EM, Heuckeroth RO (2015) Building a second brain in the bowel. J Clin Invest 125(3):899\u2013907. https:\/\/doi.org\/10.1172\/jci76307","journal-title":"J Clin Invest"},{"issue":"34","key":"917_CR4","doi-asserted-by":"publisher","first-page":"9593","DOI":"10.1073\/pnas.1609291113","volume":"113","author":"F Bassil","year":"2016","unstructured":"Bassil F et al (2016) Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy. Proc Natl Acad Sci USA 113(34):9593\u20139598. https:\/\/doi.org\/10.1073\/pnas.1609291113","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"917_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1056\/NEJM199601113340202","volume":"334","author":"DA Bennett","year":"1996","unstructured":"Bennett DA et al (1996) Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 334(2):71\u201376. https:\/\/doi.org\/10.1056\/NEJM199601113340202","journal-title":"N Engl J Med"},{"issue":"2","key":"917_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H et al (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"issue":"2","key":"917_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","volume":"1822","author":"L Breydo","year":"2012","unstructured":"Breydo L, Wu JW, Uversky VN (2012) Alpha-synuclein misfolding and Parkinson\u2019s disease. Biochim Biophys Acta 1822(2):261\u2013285. https:\/\/doi.org\/10.1016\/j.bbadis.2011.10.002","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"917_CR8","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.neurobiolaging.2008.06.010","volume":"31","author":"L Brighina","year":"2010","unstructured":"Brighina L et al (2010) Lymphomonocyte alpha-synuclein levels in aging and in Parkinson disease. Neurobiol Aging 31(5):884\u2013885. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.06.010","journal-title":"Neurobiol Aging"},{"key":"917_CR9","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/srep00910","volume":"2","author":"MH Canron","year":"2012","unstructured":"Canron MH, Perret M, Vital A, Bezard E, Dehay B (2012) Age-dependent alpha-synuclein aggregation in the Microcebus murinus lemur primate. Sci Rep 2:910. https:\/\/doi.org\/10.1038\/srep00910","journal-title":"Sci Rep"},{"issue":"1","key":"917_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.nbd.2006.08.021","volume":"25","author":"Y Chu","year":"2007","unstructured":"Chu Y, Kordower JH (2007) Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson\u2019s disease? Neurobiol Dis 25(1):134\u2013149. https:\/\/doi.org\/10.1016\/j.nbd.2006.08.021","journal-title":"Neurobiol Dis"},{"issue":"3","key":"917_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/cne.10261","volume":"450","author":"Y Chu","year":"2002","unstructured":"Chu Y, Kompoliti K, Cochran EJ, Mufson EJ, Kordower JH (2002) Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. J Comp Neurol 450(3):203\u2013214. https:\/\/doi.org\/10.1002\/cne.10261","journal-title":"J Comp Neurol"},{"issue":"16","key":"917_CR12","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","volume":"273","author":"WS Davidson","year":"1998","unstructured":"Davidson WS, Jonas A, Clayton DF, George JM (1998) Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273(16):9443\u20139449. https:\/\/doi.org\/10.1074\/jbc.273.16.9443","journal-title":"J Biol Chem"},{"issue":"12","key":"917_CR13","doi-asserted-by":"publisher","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth CB et al (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS ONE 6(12):e28032. https:\/\/doi.org\/10.1371\/journal.pone.0028032","journal-title":"PLoS ONE"},{"issue":"3","key":"917_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrn2786","volume":"11","author":"B Frost","year":"2010","unstructured":"Frost B, Diamond MI (2010) Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci 11(3):155\u2013159. https:\/\/doi.org\/10.1038\/nrn2786","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"917_CR15","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/mds.25776","volume":"29","author":"E Gelpi","year":"2014","unstructured":"Gelpi E et al (2014) Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord 29(8):1010\u20131018. https:\/\/doi.org\/10.1002\/mds.25776","journal-title":"Mov Disord"},{"issue":"7","key":"917_CR16","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/35081564","volume":"2","author":"M Goedert","year":"2001","unstructured":"Goedert M (2001) Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2(7):492\u2013501. https:\/\/doi.org\/10.1038\/35081564","journal-title":"Nat Rev Neurosci"},{"issue":"465","key":"917_CR17","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1126\/scitranslmed.aah4066","volume":"10","author":"R Gordon","year":"2018","unstructured":"Gordon R et al (2018) Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Translat Med 10(465):4066. https:\/\/doi.org\/10.1126\/scitranslmed.aah4066","journal-title":"Sci Translat Med"},{"issue":"1","key":"917_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.expneurol.2007.07.006","volume":"209","author":"GM Halliday","year":"2008","unstructured":"Halliday GM, McCann H (2008) Human-based studies on alpha-synuclein deposition and relationship to Parkinson\u2019s disease symptoms. Exp Neurol 209(1):12\u201321. https:\/\/doi.org\/10.1016\/j.expneurol.2007.07.006","journal-title":"Exp Neurol"},{"key":"917_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1749-6632.2009.04365.x","volume":"1170","author":"CH Hawkes","year":"2009","unstructured":"Hawkes CH, Del Tredici K, Braak H (2009) Parkinson\u2019s disease: the dual hit theory revisited. Ann N Y Acad Sci 1170:615\u2013622. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04365.x","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"917_CR20","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","volume":"19","author":"MT Heneka","year":"2018","unstructured":"Heneka MT, McManus RM, Latz E (2018) Inflammasome signalling in brain function and neurodegenerative disease. Nat Rev Neurosci 19(10):610\u2013621. https:\/\/doi.org\/10.1038\/s41583-018-0055-7","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"917_CR21","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist S et al (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 128(6):805\u2013820. https:\/\/doi.org\/10.1007\/s00401-014-1343-6","journal-title":"Acta Neuropathol"},{"key":"917_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41531-016-0002-0","volume":"3","author":"MC Houser","year":"2017","unstructured":"Houser MC, Tansey MG (2017) The gut-brain axis: is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis? NPJ Parkinsons Dis 3:3. https:\/\/doi.org\/10.1038\/s41531-016-0002-0","journal-title":"NPJ Parkinsons Dis"},{"issue":"10","key":"917_CR23","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.bbadis.2016.07.008","volume":"1862","author":"Q Hu","year":"2016","unstructured":"Hu Q et al (2016a) Baicalein inhibits alpha-synuclein oligomer formation and prevents progression of alpha-synuclein accumulation in a rotenone mouse model of Parkinson\u2019s disease. Biochem Biophys Acta 1862(10):1883\u20131890. https:\/\/doi.org\/10.1016\/j.bbadis.2016.07.008","journal-title":"Biochem Biophys Acta"},{"issue":"10","key":"917_CR24","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.bbadis.2016.07.008","volume":"1862","author":"Q Hu","year":"2016","unstructured":"Hu Q et al (2016b) Baicalein inhibits \u03b1-synuclein oligomer formation and prevents progression of \u03b1-synuclein accumulation in a rotenone mouse model of Parkinson\u2019s disease. Biochem Biophys Acta 1862(10):1883\u20131890. https:\/\/doi.org\/10.1016\/j.bbadis.2016.07.008","journal-title":"Biochem Biophys Acta"},{"issue":"4","key":"917_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00702-018-1898-9","volume":"126","author":"KA Jellinger","year":"2019","unstructured":"Jellinger KA (2019) Is Braak staging valid for all types of Parkinson\u2019s disease? J Neural Transm 126(4):423\u2013431. https:\/\/doi.org\/10.1007\/s00702-018-1898-9","journal-title":"J Neural Transm"},{"issue":"5","key":"917_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","volume":"125","author":"AP Kiely","year":"2013","unstructured":"Kiely AP et al (2013) alpha-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson\u2019s disease and multiple system atrophy? Acta Neuropathol 125(5):753\u2013769. https:\/\/doi.org\/10.1007\/s00401-013-1096-7","journal-title":"Acta Neuropathol"},{"issue":"2","key":"917_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger R et al (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18(2):106\u2013108. https:\/\/doi.org\/10.1038\/ng0298-106","journal-title":"Nat Genet"},{"issue":"4","key":"917_CR28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.23894","volume":"73","author":"S Lesage","year":"2013","unstructured":"Lesage S et al (2013) G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann Neurol 73(4):459\u2013471. https:\/\/doi.org\/10.1002\/ana.23894","journal-title":"Ann Neurol"},{"key":"917_CR29","doi-asserted-by":"publisher","first-page":"7400","DOI":"10.1523\/JNEUROSCI.1370-04.2004","volume":"24","author":"W Li","year":"2004","unstructured":"Li W et al (2004) Stabilization of\u202f??-synuclein protein with aging and familial Parkinson\u2019s disease-linked A53T mutation. J Neurosci 24:7400\u20137409. https:\/\/doi.org\/10.1523\/JNEUROSCI.1370-04.2004","journal-title":"J Neurosci"},{"issue":"6","key":"917_CR30","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1073\/pnas.0406976102","volume":"102","author":"W Li","year":"2005","unstructured":"Li W et al (2005) Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson\u2019s disease-linked mutations. Proc Natl Acad Sci USA 102(6):2162\u20132167. https:\/\/doi.org\/10.1073\/pnas.0406976102","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"917_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1385\/jmn:22:3:199","volume":"22","author":"S Ltic","year":"2004","unstructured":"Ltic S et al (2004) Alpha-synuclein is expressed in different tissues during human fetal development. J Molec Neurosci 22(3):199\u2013204. https:\/\/doi.org\/10.1385\/jmn:22:3:199","journal-title":"J Molec Neurosci"},{"key":"917_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.expneurol.2009.09.021","volume":"220","author":"S Mak","year":"2009","unstructured":"Mak S, McCormack A, Langston J, Kordower J, Di Monte D (2009a) Decreased \u03b1-synuclein expression in the aging mouse substantia nigra. Exp Neurol 220:359\u2013365. https:\/\/doi.org\/10.1016\/j.expneurol.2009.09.021","journal-title":"Exp Neurol"},{"issue":"2","key":"917_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.expneurol.2009.09.021","volume":"220","author":"SK Mak","year":"2009","unstructured":"Mak SK, McCormack AL, Langston JW, Kordower JH, Di Monte DA (2009b) Decreased alpha-synuclein expression in the aging mouse substantia nigra. Exp Neurol 220(2):359\u2013365. https:\/\/doi.org\/10.1016\/j.expneurol.2009.09.021","journal-title":"Exp Neurol"},{"issue":"Suppl 1","key":"917_CR34","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/s1353-8020(13)70017-8","volume":"20","author":"H McCann","year":"2014","unstructured":"McCann H, Stevens CH, Cartwright H, Halliday GM (2014) \u03b1-Synucleinopathy phenotypes. Parkinsonism Relat Disord 20(Suppl 1):S62\u2013S67. https:\/\/doi.org\/10.1016\/s1353-8020(13)70017-8","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"917_CR35","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1212\/wnl.46.4.1044","volume":"46","author":"DM Morens","year":"1996","unstructured":"Morens DM et al (1996) Epidemiologic observations on Parkinson\u2019s disease: incidence and mortality in a prospective study of middle-aged men. Neurology 46(4):1044\u20131050. https:\/\/doi.org\/10.1212\/wnl.46.4.1044","journal-title":"Neurology"},{"issue":"36","key":"917_CR36","doi-asserted-by":"publisher","first-page":"9958","DOI":"10.1073\/pnas.1610993113","volume":"113","author":"S Nuber","year":"2016","unstructured":"Nuber S, Selkoe DJ (2016) Caspase-1 clipping causes complications for alpha-synuclein. Proc Natl Acad Sci USA 113(36):9958\u20139960. https:\/\/doi.org\/10.1073\/pnas.1610993113","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"917_CR37","doi-asserted-by":"publisher","first-page":"e60378","DOI":"10.1371\/journal.pone.0060378","volume":"8","author":"AW Oaks","year":"2013","unstructured":"Oaks AW, Frankfurt M, Finkelstein DI, Sidhu A (2013) Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function. PLoS ONE 8(4):e60378. https:\/\/doi.org\/10.1371\/journal.pone.0060378","journal-title":"PLoS ONE"},{"issue":"1","key":"917_CR38","doi-asserted-by":"publisher","first-page":"e8762","DOI":"10.1371\/journal.pone.0008762","volume":"5","author":"F Pan-Montojo","year":"2010","unstructured":"Pan-Montojo F et al (2010) Progression of Parkinson\u2019s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS ONE 5(1):e8762. https:\/\/doi.org\/10.1371\/journal.pone.0008762","journal-title":"PLoS ONE"},{"issue":"9","key":"917_CR39","doi-asserted-by":"publisher","first-page":"2180.e1","DOI":"10.1016\/j.neurobiolaging.2014.03.024","volume":"35","author":"P Pasanen","year":"2014","unstructured":"Pasanen P et al (2014) Novel \u03b1-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology. Neurobiol Aging 35(9):2180.e1-2180.e5. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.03.024","journal-title":"Neurobiol Aging"},{"issue":"1","key":"917_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.expneurol.2009.07.025","volume":"220","author":"RJ Phillips","year":"2009","unstructured":"Phillips RJ, Walter GC, Ringer BE, Higgs KM, Powley TL (2009) Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat. Exp Neurol 220(1):109\u2013119. https:\/\/doi.org\/10.1016\/j.expneurol.2009.07.025","journal-title":"Exp Neurol"},{"issue":"5321","key":"917_CR41","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276(5321):2045\u20132047","journal-title":"Science"},{"issue":"1","key":"917_CR42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.nbd.2011.08.014","volume":"45","author":"H Pouclet","year":"2012","unstructured":"Pouclet H et al (2012) A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson\u2019s disease. Neurobiol Dis 45(1):305\u2013309. https:\/\/doi.org\/10.1016\/j.nbd.2011.08.014","journal-title":"Neurobiol Dis"},{"issue":"11","key":"917_CR43","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","volume":"80","author":"C Proukakis","year":"2013","unstructured":"Proukakis C et al (2013) A novel alpha-synuclein missense mutation in Parkinson disease. Neurology 80(11):1062\u20131064. https:\/\/doi.org\/10.1212\/WNL.0b013e31828727ba","journal-title":"Neurology"},{"issue":"4","key":"917_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.5114\/fn.2019.89857","volume":"57","author":"K Radad","year":"2019","unstructured":"Radad K et al (2019) Rotenone: from modelling to implication in Parkinson\u2019s disease. Folia Neuropathol 57(4):317\u2013326. https:\/\/doi.org\/10.5114\/fn.2019.89857","journal-title":"Folia Neuropathol"},{"issue":"4","key":"917_CR45","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/ana.20226","volume":"56","author":"GW Ross","year":"2004","unstructured":"Ross GW et al (2004) Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann Neurol 56(4):532\u2013539. https:\/\/doi.org\/10.1002\/ana.20226","journal-title":"Ann Neurol"},{"issue":"4","key":"917_CR46","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00401-008-0352-8","volume":"115","author":"G Rudow","year":"2008","unstructured":"Rudow G et al (2008) Morphometry of the human substantia nigra in ageing and Parkinson\u2019s disease. Acta Neuropathol 115(4):461\u2013470. https:\/\/doi.org\/10.1007\/s00401-008-0352-8","journal-title":"Acta Neuropathol"},{"issue":"9","key":"917_CR47","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1212\/WNL.0b013e31824bd195","volume":"78","author":"DR Shprecher","year":"2012","unstructured":"Shprecher DR, Derkinderen P (2012) Parkinson disease: the enteric nervous system spills its guts. Neurology 78(9):683. https:\/\/doi.org\/10.1212\/WNL.0b013e31824bd195","journal-title":"Neurology"},{"issue":"2","key":"917_CR48","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s12035-012-8334-1","volume":"47","author":"BA Silva","year":"2013","unstructured":"Silva BA, Breydo L, Uversky VN (2013) Targeting the chameleon: a focused look at alpha-synuclein and its roles in neurodegeneration. Mol Neurobiol 47(2):446\u2013459. https:\/\/doi.org\/10.1007\/s12035-012-8334-1","journal-title":"Mol Neurobiol"},{"issue":"3","key":"917_CR49","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nri2725","volume":"10","author":"J Tschopp","year":"2010","unstructured":"Tschopp J, Schroder K (2010) NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10(3):210\u2013215. https:\/\/doi.org\/10.1038\/nri2725","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"917_CR50","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1460-9568.2010.07284.x","volume":"32","author":"A Ulusoy","year":"2010","unstructured":"Ulusoy A, Febbraro F, Jensen PH, Kirik D, Romero-Ramos M (2010) Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology. Eur J Neurosci 32(3):409\u2013422. https:\/\/doi.org\/10.1111\/j.1460-9568.2010.07284.x","journal-title":"Eur J Neurosci"},{"key":"917_CR51","doi-asserted-by":"publisher","first-page":"525","DOI":"10.12688\/f1000research.10536.1","volume":"6","author":"VN Uversky","year":"2017","unstructured":"Uversky VN (2017) Looking at the recent advances in understanding alpha-synuclein and its aggregation through the proteoform prism. F1000Research 6:525. https:\/\/doi.org\/10.12688\/f1000research.10536.1","journal-title":"F1000Research"},{"issue":"34","key":"917_CR52","doi-asserted-by":"publisher","first-page":"9587","DOI":"10.1073\/pnas.1610099113","volume":"113","author":"W Wang","year":"2016","unstructured":"Wang W et al (2016) Caspase-1 causes truncation and aggregation of the Parkinson\u2019s disease-associated protein \u03b1-synuclein. Proc Natl Acad Sci USA 113(34):9587\u20139592. https:\/\/doi.org\/10.1073\/pnas.1610099113","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"917_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong YC, Krainc D (2017) \u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med 23(2):1\u201313. https:\/\/doi.org\/10.1038\/nm.4269","journal-title":"Nat Med"},{"issue":"2","key":"917_CR54","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ et al (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55(2):164\u2013173. https:\/\/doi.org\/10.1002\/ana.10795","journal-title":"Ann Neurol"},{"issue":"5","key":"917_CR55","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s12264-017-0179-1","volume":"33","author":"CB Zhong","year":"2017","unstructured":"Zhong CB et al (2017) Age-dependent alpha-synuclein accumulation and phosphorylation in the enteric nervous system in a transgenic mouse model of parkinson\u2019s disease. Neurosci Bull 33(5):483\u2013492. https:\/\/doi.org\/10.1007\/s12264-017-0179-1","journal-title":"Neurosci Bull"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-022-00917-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-022-00917-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-022-00917-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T02:15:32Z","timestamp":1652840132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-022-00917-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["917"],"URL":"https:\/\/doi.org\/10.1007\/s11011-022-00917-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1095808\/v1","asserted-by":"object"}]},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,28]]},"assertion":[{"value":"29 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Tongji Hospital animal Care and Use Committee in line with the USA National Institutes of Health (NIH) guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that there is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}